Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), sold 67,696 shares at $11.72 ($793K) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Open-market sale of $793k PHAT by President and Chief Executive. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.72 | 33,848 | $397K | 50.0% |
| 2 | $11.72 | 33,848 | $397K | 50.0% |
| Total | $11.72 avg | 67,696 | $793K | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-03-26 | $307K | — | Filing → |